Positive results of Drug Trial re MSA inc MSA-C

In this trial, ATH434 was compared to placebo in participants with early-stage MSA, including MSA-C. People with MSA-C are often misdiagnosed with cerebellar ataxia, because the symptoms can be similar in both conditions. This trial had sites in the UK.